Last deal

$3M

Amount

Grant

Stage

12.09.2022

Date

3

all rounds

$7.8M

Total amount

date founded

Financing round

General

About Company
Aldatu Biosciences is an early-stage biotechnology company providing diagnostic services for infectious diseases.

Industry

Sector :

Subsector :

founded date

07.01.2014

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The Boston-based company has developed a proprietary genotyping platform called PANDAA, which enables high-throughput infectious disease diagnostics and improves patient access to diagnostics in resource-limited countries. Aldatu Biosciences is committed to commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases. Their PANDAA qDx™ SARS-CoV-2 assay is being implemented in numerous clinical labs, and they have established Aldatu Diagnostics, a clinical lab dedicated to supporting the community's needs for COVID-19 testing using their PANDAA technology.
Contacts

Contact Email

Social url

Similar Companies
1000
nVector, Inc.

nVector, Inc.

nVector is a company developing next-generation gene therapy technology for treating central nervous system diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Health Diagnostics

Location

Phoenix, AZ, USA

total rounds

1
Day Zero Diagnostics

Day Zero Diagnostics

Day Zero Diagnostics uses whole-genome sequencing to create sequencing-based diagnostics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Health Diagnostics

Location

Boston, MA, USA

total rounds

11

total raised

$54.4M
Biocartis

Biocartis

Biocartis is a molecular diagnostics company.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Lausanne, Switzerland

total rounds

9

total raised

$338.83M

count Of Investments

2
Bertis

Bertis

BERTIS Inc. is a leading proteomics company in Korea that develops diagnostic services for early detection of cancer and various diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Poughkeepsie, NY, USA

total rounds

2

total raised

$28.03M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$7.8M

Money Raised

Their latest funding was raised on 12.09.2022. Their latest investor Springhood. Their latest round Grant

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

NIAID conducts research to prevent and treat infectious and allergic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

101

count Of Exists

3
National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious is a medical research agency that supports basic and applied research for allergic diseases.

count Of Investments

75

count Of Exists

3
Massachusetts Life Sciences Center

Massachusetts Life Sciences Center

The Massachusetts Life Sciences Center (MLSC) supports the growth of life sciences in Massachusetts.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Waltham, MA, USA

total rounds

2

total raised

$6.22M

count Of Investments

159

count Of Exists

7
National Institutes of Health

National Institutes of Health

NIH conducts research to improve health and reduce illness and disability.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Software, Government

Location

Bethesda, MD, USA

total rounds

1

total raised

$5M

count Of Investments

827

count Of Exists

31
Co-Investors
Investors
7
4

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 

Springhood

Investing in startups solving major issues in children's health.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care

count Of Investments

6
National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

NIAID conducts research to prevent and treat infectious and allergic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

101

count Of Exists

3
National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious Diseases

National Institute of Allergy and Infectious is a medical research agency that supports basic and applied research for allergic diseases.

count Of Investments

75

count Of Exists

3

People

Founders
2
David Raiser
David Raiser

David Raiser

David Raiser is the Founder and CEO at Aldatu Biosciences.

current job

Aldatu Biosciences
Aldatu Biosciences

organization founded

1

David Raiser

Iain MacLeod
Iain MacLeod

Iain MacLeod

Iain is responsible for leading the advancement of Aldatu’s pathogen and drug resistance diagnostic technology in addition to guiding the company’s global health strategy. Iain maintains an academic appointment at the Harvard School of Public Health AIDS Initiative. He undertook his post-doctoral training at the Harvard School of Public Health, and the Botswana-Harvard AIDS Institute in Gaborone, Botswana, where he focused on HIV drug resistance. Iain holds a Ph.D. in Pathology – specializing in molecular virology – from the University of Cambridge (2008), an LL.M. in International Law, and a B.Sc. in Virology from the University of Glasgow.

current job

Aldatu Biosciences
Aldatu Biosciences

organization founded

1

Iain MacLeod

Employee Profiles
4
Iain MacLeod

Iain MacLeod

Co-Founder ,CSO & CEO

David Raiser

David Raiser

Co-Founder & Chairman of the Board

Haifa Ghandour

Lead scientist

Betsy Wonderly Trainor

Betsy Wonderly Trainor

VP Development

Activity

Recent News
0